Purified protein derivatives of tuberculin - past, present, and future

FEMS Immunology and Medical Microbiology

Volumn 66, Issue 3, 2012, Pages 273-280

  Yang, Hongliang ^a   Kruh Garcia, Nicole A ^a   Dobos, Karen M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Diagnosis; Purified protein derivative; Tuberculin skin test; Tuberculosis

Indexed keywords

BCG VACCINE; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; N,N' DIPHENYL 1,4 PHENYLENEDIAMINE; PROTEIN DNAK; PROTEIN GROEL2; PROTEIN MPT64; PROTEIN TPA38; RECOMBINANT PROTEIN; RIBOSOMAL PROTEIN L12; RIBOSOMAL PROTEIN L7; TUBERCULIN; UNCLASSIFIED DRUG;

BCG VACCINATION; DRUG FORMULATION; DRUG POTENCY; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; TUBERCULIN TEST; TUBERCULOSIS;

ANIMALS; GUINEA PIGS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; TUBERCULIN; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 84869862467     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2012.01002.x     Document Type: Short Survey

References (77)

1. Aagaard C, Brock I, Olsen A, Ottenhoff TH, Weldingh K & Andersen P (2004) Mapping immune reactivity toward Rv2653 and Rv2654: two novel low-molecular-mass antigens found specifically in the Mycobacterium tuberculosis complex. J Infect Dis 189: 812-819.
2. Addo KK, Hof SV, Mensah GI, Hesse A, Bonsu C, Koram KA, Afutu FK & Bonsu FA (2010) A tuberculin skin test survey among Ghanaian school children. BMC Public Health 10: 35.
3. Aggerbeck H & Madsen SM (2006) Safety of ESAT-6. Tuberculosis (Edinb) 86: 363-373.
4. Al-Absi A, Bassili A, Abdul Bary H, Barker A, Daniels M, Munim A, Seita A, Williams B & Dye C (2009) The decline of tuberculosis in Yemen: evaluation based on two nationwide tuberculin surveys. Int J Tuberc Lung Dis 13: 1100-1105.
5. Arend SM, Franken WP, Aggerbeck H, Prins C, van Dissel JT, Thierry-Carstensen B, Tingskov PN, Weldingh K & Andersen P (2008) Double-blind randomized Phase I study comparing rdESAT-6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infection. Tuberculosis (Edinb) 88: 249-261.
6. Bachtiar A, Miko TY, Machmud R et al. (2008) Annual risk of tuberculosis infection in West Sumatra Province, Indonesia. Int J Tuberc Lung Dis 12: 255-261.
7. Borgen K, Koster B, Meijer H, Kuyvenhoven V, van der Sande M & Cobelens F (2008) Evaluation of a large-scale tuberculosis contact investigation in the Netherlands. Eur Respir J 32: 419-425.
8. Borsuk S, Newcombe J, Mendum TA, Dellagostin OA & McFadden J (2009) Identification of proteins from tuberculin purified protein derivative (PPD) by LC-MS/MS. Tuberculosis (Edinb) 89: 423-430.
9. Bothamley GH, Catty D, Clifton-Hadley R, Griffin F, Hewinson G & Pollock J (1999) Imunodiagnosis of Mycobacterial Infection (Chapter 10). Blackwell Science Ltd, Oxford.
10. Brusasca PN, Colangeli R, Lyashchenko KP, Zhao X, Vogelstein M, Spencer JS, McMurray DN & Gennaro ML (2001) Immunological characterization of antigens encoded by the RD1 region of the Mycobacterium tuberculosis genome. Scand J Immunol 54: 448-452.
11. Campos-Neto A, Rodrigues-Junior V, Pedral-Sampaio DB, Netto EM, Ovendale PJ, Coler RN, Skeiky YA, Badaro R & Reed SG (2001) Evaluation of DPPD, a single recombinant Mycobacterium tuberculosis protein as an alternative antigen for the Mantoux test. Tuberculosis (Edinb) 81: 353-358.
12. Chadha VK, Jagannatha PS, Vaidyanathan PS & Jagota P (2003) PPD RT23 for tuberculin surveys in India. Int J Tuberc Lung Dis 7: 172-179.
13. Chambers MA, Jahans K, Whelan A, Hughes C, Sayers R, Perkins A & Glyn Hewinson R (2002) Simple objective measurement of the cutaneous delayed-type hypersensitivity reaction to tuberculin using spectrophotometry. Skin Res Technol 8: 89-93.
14. Chang KC & Leung CC (2010) Systematic review of interferon-gamma release assays in tuberculosis: focus on likelihood ratios. Thorax 65: 271-276.
15. Cho YS, Dobos KM, Prenni J et al. (2012) Deciphering the proteome of the in vivo diagnostic reagent "purified protein derivative" from Mycobacterium tuberculosis. Proteomics 12: 979-991.
16. Ciftci E, Ilgazli A, Gulleroglu B, Ara I & Akansel G (2005) Ultrasonographic measurement of the tuberculin skin test: comparison with manual reading. Infect Dis Clin Pract (Baltim Md) 13: 20-23.
17. Colangeli R, Spencer JS, Bifani P, Williams A, Lyashchenko K, Keen MA, Hill PJ, Belisle J & Gennaro ML (2000) MTSA-10, the product of the Rv3874 gene of Mycobacterium tuberculosis, elicits tuberculosis-specific, delayed-type hypersensitivity in guinea pigs. Infect Immun 68: 990-993.
18. Coler RN, Skeiky YA, Ovendale PJ, Vedvick TS, Gervassi L, Guderian J, Jen S, Reed SG & Campos-Neto A (2000) Cloning of a Mycobacterium tuberculosis gene encoding a purifed protein derivative protein that elicits strong tuberculosis-specific delayed-type hypersensitivity. J Infect Dis 182: 224-233.
19. Comstock GW, Edwards LB, Philip RN & Winn WA (1964) A comparison in the United States of America of two tuberculins, Ppd-S and Rt 23. Bull World Health Organ 31: 161-170.
20. Dye C, Scheele S, Dolin P, Pathania V & Raviglione MC (1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282: 677-686.
21. Edwards PQ & Edwads LB (1960) Story of the tuberculin test from an epidemiologic viewpoint. Am Rev Respir Dis 81(Pt 2): 1-47.
22. Elhay MJ, Oettinger T & Andersen P (1998) Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the guinea pig. Infect Immun 66: 3454-3456.
23. Farhat M, Greenaway C, Pai M & Menzies D (2006) False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 10: 1192-1204.
24. Fernandez-Villar A, Goris A, Otero M, Choucino N, Vazquez R, Munoz MJ & Pineiro L (2004) Conservation of purified protein derivative RT-23 tuberculin. Arch Bronconeumol 40: 301-303.
25. Gillenwater KA, Sapp SC, Pearce K & Siberry GK (2006) Increase in tuberculin skin test converters among health care workers after a change from Tubersol to Aplisol. Am J Infect Control 34: 651-654.
26. Guld J, Bentzon MW, Bleiker MA, Griep WA, Magnusson M & Waaler H (1958) Standardization of a new batch of purified tuberculin (PPD) intended for international use. Bull World Health Organ 19: 845-951.
27. Hanifa Y, Grant AD, Lewis J, Corbett EL, Fielding K & Churchyard G (2009) Prevalence of latent tuberculosis infection among gold miners in South Africa. Int J Tuberc Lung Dis 13: 39-46.
28. Hansen OG, Lindqvist K & Waaler H (1964) Assessment of the potency of tuberculin in humans and guinea-pigs. Bull World Health Organ 31: 171-182.
29. Harboe M (1981) Antigens of PPD, old tuberculin, and autoclaved Mycobacterium bovis BCG studied by crossed immunoelectrophoresis. Am Rev Respir Dis 124: 80-87.
30. Harrison DK, Abbot NC, Beck JS & McCollum PT (1993) A preliminary assessment of laser Doppler perfusion imaging in human skin using the tuberculin reaction as a model. Physiol Meas 14: 241-252.
31. He XY, Luo YA, Zhang XG et al. (2008) Clinical evaluation of the recombinant 38 kDa protein of Mycobacterium tuberculosis. Scand J Infect Dis 40: 121-126.
32. Ho MM, Kairo SK & Corbel MJ (2006) Tuberculin purified protein derivative (PPD) immunoassay as an in vitro alternative assay for identity and confirmation of potency. Hum Vaccin 2: 29-33.
33. Huebner RE, Schein MF & Bass JB Jr (1993) The tuberculin skin test. Clin Infect Dis 17: 968-975.
34. Jensen PA, Lambert LA, Iademarco MF & Ridzon R (2005) Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 54: 1-141.
35. Kimura M, Comstock GW & Mori T (2005) Comparison of erythema and induration as results of tuberculin tests. Int J Tuberc Lung Dis 9: 853-857.
36. Kitaura H, Kinomoto M & Yamada T (1999) Ribosomal protein L7 included in tuberculin purified protein derivative (PPD) is a major heat-resistant protein inducing strong delayed-type hypersensitivity. Scand J Immunol 50: 580-587.
37. Klausen J, Magnusson M, Andersen AB & Koch C (1994) Characterization of purified protein derivative of tuberculin by use of monoclonal antibodies: isolation of a delayed-type hypersensitivity reactive component from M. tuberculosis culture filtrate. Scand J Immunol 40: 345-349.
38. Kritzinger FE, den Boon S, Verver S, Enarson DA, Lombard CJ, Borgdorff MW, Gie RP & Beyers N (2009) No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa. Trop Med Int Health 14: 136-142.
39. Li J, Munsiff SS & Agerton TB (2010) Prevalence of tuberculin skin test positivity in clinical population in New York City. J Immigr Minor Health 12: 816-822.
40. Liu C, Flamoe E, Chen HJ, Carter D, Reed SG & Campos-Neto A (2004) Expression and purification of immunologically reactive DPPD, a recombinant Mycobacterium tuberculosis skin test antigen, using Mycobacterium smegmatis and Escherichia coli host cells. Can J Microbiol 50: 97-105.
41. Lopes LK, Teles SA, Souza AC, Rabahi MF & Tipple AF (2008) Tuberculosis risk among nursing professionals from Central Brazil. Am J Infect Control 36: 148-151.
42. Lyashchenko K, Manca C, Colangeli R, Heijbel A, Williams A & Gennaro ML (1998) Use of Mycobacterium tuberculosis complex-specific antigen cocktails for a skin test specific for tuberculosis. Infect Immun 66: 3606-3610.
43. Mackin LA (1998) Screening for tuberculosis in the primary care setting. Lippincotts Prim Care Pract 2: 599-610; quiz 611-593.
44. Maes M, Gimenez JF, D'Alessandro A & De Waard JH (2011) The stability of human, bovine and avian tuberculin purified protein derivative (PPD). J Infect Dev Ctries 5: 781-785.
45. Mahairas GG, Sabo PJ, Hickey MJ, Singh DC & Stover CK (1996) Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 178: 1274-1282.
46. Masucci P & McAlpine KL (1930) Biochemical studies of bacterial derivatives. X. Preparation of human tubercle bacillus protein MA-100. Proc Soc Exp Biol Med 27: 661-663.
47. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B & Vernon A; Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC) (2005) Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 54(RR-15): 49-55.
48. Mehta SR, MacGruder C, Looney D, Johns S & Smith DM (2009) Differences in tuberculin reactivity as determined in a veterans administration employee health screening program. Clin Vaccine Immunol 16: 541-543.
49. Mustafa AS (2001) Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis. Curr Pharm Biotechnol 2: 157-173.
50. Mustafa AS (2002) Development of new vaccines and diagnostic reagents against tuberculosis. Mol Immunol 39: 113-119.
51. Oettinger T, Holm A, Mtoni IM, Andersen AB & Hasloov K (1995) Mapping of the delayed-type hypersensitivity-inducing epitope of secreted protein MPT64 from Mycobacterium tuberculosis. Infect Immun 63: 4613-4618.
52. Olsen AW, Hansen PR, Holm A & Andersen P (2000) Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. Eur J Immunol 30: 1724-1732.
53. Pollock JM, McNair J, Bassett H, Cassidy JP, Costello E, Aggerbeck H, Rosenkrands I & Andersen P (2003) Specific delayed-type hypersensitivity responses to ESAT-6 identify tuberculosis-infected cattle. J Clin Microbiol 41: 1856-1860.
54. Rangel-Frausto MS, Ponce-De-Leon-Rosales S, Martinez-Abaroa C & Haslov K (2001) Tuberculosis and tuberculin quality: best intentions, misleading results. Infect Control Hosp Epidemiol 22: 481-484.
55. Rao VG, Gopi PG, Yadav R et al. (2008) Annual risk of tuberculosis infection among tribal population of central India. Trop Med Int Health 13: 1372-1377.
56. Renshaw PS, Panagiotidou P, Whelan A, Gordon SV, Hewinson RG, Williamson RA & Carr MD (2002) Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6*CFP-10 complex. Implications for pathogenesis and virulence. J Biol Chem 277: 21598-21603.
57. Rhodes SG, Gavier-Widen D, Buddle BM, Whelan AO, Singh M, Hewinson RG & Vordermeier HM (2000) Antigen specificity in experimental bovine tuberculosis. Infect Immun 68: 2573-2578.
58. Rowland SS, Ruckert JL & Cummings PJ (1999) Low molecular mass protein patterns in mycobacterial culture filtrates and purified protein derivatives. FEMS Immunol Med Microbiol 23: 21-25.
59. Sbarbaro JA (1978) Skin test antigens: an evaluation whose time has come. Am Rev Respir Dis 118: 1-5.
60. Schiller I, Vordermeier HM, Waters WR et al. (2010) Comparison of tuberculin activity using the interferon-gamma assay for the diagnosis of bovine tuberculosis. Vet Rec 167: 322-326.
61. Seibert FB (1934) The isolation and properties of the purified protein derivative of tuberculin. Am Rev Tuberc 30: 713-720.
62. Seibert FB & Glen JT (1941) PPD-S was comprised of approximately 92.1% protein, 5.9% polysaccharides and 1.2% nucleic acid. Am Rev Tuberc 44: 9-24.
63. Sgountzos V, Simopoulou S, Kretsou S, Sakayianni K, Pavlerou S, Gourgoulianis K & Grigorakos L (2009) Comparative study of RT23 and Merieux tuberculin tested among healthy volunteers. Int J Tuberc Lung Dis 13: 312-316.
64. Shigeto E (1990) [Purified protein derivatives prepared from Mycobacterium tuberculosis (PPDs) and M. intracellulare (PPD-B) in differential diagnosis of mycobacteriosis]. Kekkaku 65: 701-709.
65. Shingadia D & Novelli V (2008) The tuberculin skin test: a hundred, not out? Arch Dis Child 93: 189-190.
66. Shrestha KB, Malla P, Jha KK, Shakya TM, Akhtar M, Gunneberg C & van der Werf MJ (2008) First national tuberculin survey in Nepal. Int J Tuberc Lung Dis 12: 909-915.
67. Teixeira L, Maciel E, Dutra ME, Perkins MD, Johnson JL & do Valle Dettoni V (2000) Simultaneous comparison of reactivity to purified protein derivative RT-23 and Tubersol in health care workers in Vitoria, Brazil. Int J Tuberc Lung Dis 4: 1074-1077.
68. Turk JL (1987) Von Pirquet, allergy and infectious diseases: a review. J R Soc Med 80: 31-33.
69. Ulea I, Murgoci G, Popa ML, Popa L & Stavri H (2010) Comparative study of RT23 and IC-65 tuberculins tested on children with tuberculosis. Roum Arch Microbiol Immunol 69: 75-78.
70. van Pinxteren LA, Ravn P, Agger EM, Pollock J & Andersen P (2000) Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol 7: 155-160.
71. Vashishtha VM & John TJ (2010) Prevalence of Mycobacterium tuberculosis infection in children in western Uttar Pradesh. Indian Pediatr 47: 97-100.
72. Villarino ME, Burman W, Wang YC, Lundergan L, Catanzaro A, Bock N, Jones C & Nolan C (1999) Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection. JAMA 281: 169-171.
73. Villarino ME, Brennan MJ, Nolan CM, Catanzaro A, Lundergan LL, Bock NN, Jones CL, Wang YC & Burman WJ (2000) Comparison testing of current (PPD-S1) and proposed (PPD-S2) reference tuberculin standards. Am J Respir Crit Care Med 161: 1167-1171.
74. Wang Z, Potter BM, Gray AM, Sacksteder KA, Geisbrecht BV & Laity JH (2007) The solution structure of antigen MPT64 from Mycobacterium tuberculosis defines a new family of beta-grasp proteins. J Mol Biol 366: 375-381.
75. WHO (2011) Global Tuberculosis Control: World Health Organization Report 2011. WHO, Geneva.
76. Wu X, Zhang L, Zhang J, Zhang C, Zhu L & Shi Y (2008) Recombinant early secreted antigen target 6 protein as a skin test antigen for the specific detection of Mycobacterium tuberculosis infection. Clin Exp Immunol 152: 81-87.
77. Yang HL, Troudt J, Grover A, Arnett K, Lucas M, Cho YS, Bielefeldt-Ohmann H, Taylor J, Izzo A & Dobos KM (2011) Three protein-cocktails mediate DTH responses indistinguishable from PPD in the guinea pig model of Mycobacterium tuberculosis. Infect Immun 79: 716-723.